Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.
CAS
PubMed
Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Article
Google Scholar
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
Article
Google Scholar
Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104–14.
Article
Google Scholar
Lau ES, Paniagua SM, Liu E, Jovani M, Li SX, Takvorian K, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3(1):48–58.
Article
Google Scholar
Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, et al. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia. 2017;60(6):1022–32.
Article
Google Scholar
Petrelli F, Ghidini A, Cabiddu M, Perego G, Lonati V, Ghidini M, et al. Effects of hypertension on cancer survival: a meta-analysis. Eur J Clin Invest. 2021;51(6):e13493.
Article
Google Scholar
Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–41.
Article
Google Scholar
Hu D, Peng F, Lin X, Chen G, Zhang H, Liang B, et al. Preoperative metabolic syndrome is predictive of significant gastric cancer mortality after gastrectomy: the Fujian Prospective Investigation of Cancer (FIESTA) Study. EBioMedicine. 2017;15:73–80.
Article
Google Scholar
Cho MH, Yoo TG, Jeong SM, Shin DW. Association of aspirin, metformin, and statin use with gastric cancer incidence and mortality: a Nationwide Cohort Study. Cancer Prev Res (Phila). 2021;14(1):95–104.
Article
CAS
Google Scholar
Chung WS, Le PH, Kuo CJ, Chen TH, Kuo CF, Chiou MJ, et al. Impact of metformin use on survival in patients with gastric cancer and diabetes mellitus following gastrectomy. Cancers (Basel). 2020;12(8):2013.
Article
CAS
Google Scholar
Fan GF, Pan JJ, Fan PS, Zhang TY, Liu YB, Huang J, et al. The clinical observation of verapamil in combination with interventional chemotherapy in advanced gastric cancer. Eur Rev Med Pharmacol Sci. 2018;22(17):5508–18.
PubMed
Google Scholar
Dulskas A, Patasius A, Linkeviciute-Ulinskiene D, Zabuliene L, Smailyte G. A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer. Aging (Albany NY). 2019;11(17):7197–205.
Article
CAS
Google Scholar
Hosio M, Urpilainen E, Hautakoski A, Marttila M, Arffman M, Sund R, et al. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes. Sci Rep. 2021;11(1):10445.
Article
CAS
Google Scholar
Hu D, Peng F, Lin X, Chen G, Liang B, Li C, et al. The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study. Oncotarget. 2016;7(40):65247–56.
Article
Google Scholar
Peng F, Hu D, Lin X, Chen G, Liang B, Zhang H, et al. Analysis of preoperative metabolic risk factors affecting the prognosis of patients with Esophageal squamous cell carcinoma: the Fujian Prospective Investigation of Cancer (FIESTA) Study. EBioMedicine. 2017;16:115–23.
Article
Google Scholar
Peng F, Hu D, Lin X, Liang B, Chen Y, Zhang H, et al. Impact of long-term antihypertensive and antidiabetic medications on the prognosis of post-surgical colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study. Aging (Albany NY). 2018;10(5):1166–81.
Article
CAS
Google Scholar
Tseng CH. Diabetes, insulin use, and gastric cancer: a population-based analysis of the Taiwanese. J Clin Gastroenterol. 2013;47(6):e60-64.
Article
Google Scholar
Tian T, Zhang LQ, Ma XH, Zhou JN, Shen J. Diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis. Exp Clin Endocrinol Diabetes. 2012;120(4):217–23.
Article
CAS
Google Scholar
Li W, Liu H, Qian W, Cheng L, Yan B, Han L, et al. Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer. Comput Struct Biotechnol J. 2018;16:479–87.
Article
CAS
Google Scholar
Kwon HJ, Park MI, Park SJ, Moon W, Kim SE, Kim JH, et al. Insulin resistance is associated with early gastric cancer: a prospective multicenter case control study. Gut Liver. 2019;13(2):154–60.
Article
CAS
Google Scholar
Gopal S, Miller KB, Jaffe IZ. Molecular mechanisms for vascular complications of targeted cancer therapies. Clin Sci (Lond). 2016;130(20):1763–79.
Article
CAS
Google Scholar
Kenzik KM, Balentine C, Richman J, Kilgore M, Bhatia S, Williams GR. New-onset cardiovascular morbidity in older adults with stage I to III colorectal cancer. J Clin Oncol. 2018;36(6):609–16.
Article
CAS
Google Scholar
Panneerpandian P, Rao DB, Ganesan K. Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-beta mediated transcription and sensitize the gastric cancer cells to doxorubicin. Toxicol In Vitro. 2021;74:105152.
Article
CAS
Google Scholar
Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022;603(7899):159–65.
Article
CAS
Google Scholar
Luo Z, Zhu T, Luo W, Lv Y, Zhang L, Wang C, et al. Metformin induces apoptotic cytotoxicity depending on AMPK/PKA/GSK-3beta-mediated c-FLIPL degradation in non-small cell lung cancer. Cancer Manag Res. 2019;11:681–9.
Article
CAS
Google Scholar
Cha JH, Yang WH, Xia W, Wei Y, Chan LC, Lim SO, et al. Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1. Mol Cell. 2018;71(4):606–620 e607.
Lu H, Han X, Ren J, Ren K, Li Z, Zhang Q. Metformin attenuates synergic effect of diabetes mellitus and Helicobacter pylori infection on gastric cancer cells proliferation by suppressing PTEN expression. J Cell Mol Med. 2021;25(10):4534–42.
Article
CAS
Google Scholar
Shiozaki A, Katsurahara K, Kudou M, Shimizu H, Kosuga T, Ito H, et al. Amlodipine and verapamil, voltage-gated Ca(2+) channel inhibitors, suppressed the growth of gastric cancer stem cells. Ann Surg Oncol. 2021;28(9):5400–11.
Article
Google Scholar
Li B, Cheung KS, Wong IY, Leung WK, Law S. Calcium channel blockers are associated with lower gastric cancer risk: a territory-wide study with propensity score analysis. Int J Cancer. 2021;148(9):2148–57.
Article
CAS
Google Scholar